387 related articles for article (PubMed ID: 10975073)
1. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of structure and antigenic activity of lipopolysaccharides of genus Francisella].
Maslova NN; Pavlovich NV; Sorokin VM; Zurabian VA
Mol Gen Mikrobiol Virusol; 1998; (3):26-9. PubMed ID: 9819824
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria].
Aronova NV; Pavlovich NV
Mol Gen Mikrobiol Virusol; 2001; (2):26-30. PubMed ID: 11449797
[TBL] [Abstract][Full Text] [Related]
4. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens.
Thomas RM; Titball RW; Oyston PC; Griffin K; Waters E; Hitchen PG; Michell SL; Grice ID; Wilson JC; Prior JL
Infect Immun; 2007 Jan; 75(1):371-8. PubMed ID: 17074846
[TBL] [Abstract][Full Text] [Related]
5. [The role of lipopolysaccharide in toxicity of Francisella genus bacteria].
Onoprienko NN; Pavlovich NV
Mol Gen Mikrobiol Virusol; 2003; (3):25-8. PubMed ID: 12966923
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the core part of the lipopolysaccharide O-antigen of Francisella novicida (U112).
Vinogradov E; Perry MB
Carbohydr Res; 2004 Jun; 339(9):1643-8. PubMed ID: 15183739
[TBL] [Abstract][Full Text] [Related]
7. [Phase variations of Francisella tularensis lipopolysaccharide in human infection and immunization].
Aronova NV; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2005; (4):8-12. PubMed ID: 16146218
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112).
Vinogradov E; Conlan WJ; Gunn JS; Perry MB
Carbohydr Res; 2004 Feb; 339(3):649-54. PubMed ID: 15013402
[TBL] [Abstract][Full Text] [Related]
9. [The C antigen of Francisella tularensis].
Sukhar' VV; Uraleva VS
Mikrobiol Zh (1978); 1992; 54(2):42-6. PubMed ID: 1374833
[TBL] [Abstract][Full Text] [Related]
10. Modulation of biogenesis of the Francisella tularensis subsp. novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-gamma.
Santic M; Molmeret M; Abu Kwaik Y
Cell Microbiol; 2005 Jul; 7(7):957-67. PubMed ID: 15953028
[TBL] [Abstract][Full Text] [Related]
11. [Francisella tularensis and tularemia in Turkey].
Gürcan S
Mikrobiyol Bul; 2007 Oct; 41(4):621-36. PubMed ID: 18173084
[TBL] [Abstract][Full Text] [Related]
12. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
[TBL] [Abstract][Full Text] [Related]
13. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
14. Type II secretion and type IV pili of Francisella.
Forsberg A; Guina T
Ann N Y Acad Sci; 2007 Jun; 1105():187-201. PubMed ID: 17435117
[TBL] [Abstract][Full Text] [Related]
15. Differential Substrate Usage and Metabolic Fluxes in
Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
[No Abstract] [Full Text] [Related]
16. A Francisella tularensis pathogenicity island required for intramacrophage growth.
Nano FE; Zhang N; Cowley SC; Klose KE; Cheung KK; Roberts MJ; Ludu JS; Letendre GW; Meierovics AI; Stephens G; Elkins KL
J Bacteriol; 2004 Oct; 186(19):6430-6. PubMed ID: 15375123
[TBL] [Abstract][Full Text] [Related]
17. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity.
Raynaud C; Meibom KL; Lety MA; Dubail I; Candela T; Frapy E; Charbit A
Infect Immun; 2007 Jan; 75(1):536-41. PubMed ID: 17030571
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the lipopolysaccharide and beta-glucan of the fish pathogen Francisella victoria.
Kay W; Petersen BO; Duus JØ; Perry MB; Vinogradov E
FEBS J; 2006 Jul; 273(13):3002-13. PubMed ID: 16759227
[TBL] [Abstract][Full Text] [Related]
19. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease.
Hollis DG; Weaver RE; Steigerwalt AG; Wenger JD; Moss CW; Brenner DJ
J Clin Microbiol; 1989 Jul; 27(7):1601-8. PubMed ID: 2671019
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
